share_log

Doctorglasses ChainLtd's (SZSE:300622) Five-year Earnings Growth Trails the 9.2% YoY Shareholder Returns

Doctorglasses ChainLtd's (SZSE:300622) Five-year Earnings Growth Trails the 9.2% YoY Shareholder Returns

Doctorglasses ChainLtd(深交所代碼:300622)在五年收益增長方面落後於股東9.2%的年同比回報。
Simply Wall St ·  07/29 21:38

Stock pickers are generally looking for stocks that will outperform the broader market. Buying under-rated businesses is one path to excess returns. For example, long term Doctorglasses Chain Co.,Ltd. (SZSE:300622) shareholders have enjoyed a 38% share price rise over the last half decade, well in excess of the market return of around 0.5% (not including dividends).

股票選擇者通常希望選出的股票會跑贏整個市場。購買被低估的企業是獲得超額回報的一種方式。例如,長揸博士眼鏡股份有限公司(SZSE:300622)的股東在過去的半個十年中,股價上漲了38%,遠遠超過市場回報率0.5%(不包括股息)。

Since the stock has added CN¥383m to its market cap in the past week alone, let's see if underlying performance has been driving long-term returns.

由於該股票過去一週市值增加了人民幣3,8300萬,讓我們看看潛在的業績是否推動了長期回報。

In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

在他的《格雷厄姆和道德斯維爾的超級投資者》一文中,禾倫·巴菲特描述了股價並不總是合理反映企業價值的方法。檢驗市場情緒如何隨時間變化的一種方法是觀察公司股價和每股收益(EPS)之間的互動關係。

Over half a decade, Doctorglasses ChainLtd managed to grow its earnings per share at 13% a year. The EPS growth is more impressive than the yearly share price gain of 7% over the same period. So one could conclude that the broader market has become more cautious towards the stock.

在過去的五年中,Doctorglasses Chain Ltd的每股收益年均增長率達到了13%,這一指標比同期股價每年增長7%更爲出色,因此我們可以得出結論,整個市場已對該股變得更加謹慎。

The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers).

該公司的每股收益(隨時間的推移)如下圖所示(單擊可查看確切數字)。

big
SZSE:300622 Earnings Per Share Growth July 30th 2024
SZSE:300622每股收益增長2024年7月30日

This free interactive report on Doctorglasses ChainLtd's earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further.

如果您想進一步調查該股票,博士眼鏡股份有限公司的盈利、營業收入和現金流的這份免費交互式報告是一個很好的起點。

What About Dividends?

那麼分紅怎麼樣呢?

As well as measuring the share price return, investors should also consider the total shareholder return (TSR). The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. In the case of Doctorglasses ChainLtd, it has a TSR of 55% for the last 5 years. That exceeds its share price return that we previously mentioned. This is largely a result of its dividend payments!

除了衡量股價回報外,投資者還應該考慮總股東回報率(TSR)。TSR包括任何分拆或折價增發的價值以及任何股息,假定股息再投資。因此,對於那些支付慷慨股息的公司,TSR通常比股價回報率高得多。就博士眼鏡股份有限公司而言,它在過去5年中的TSR爲55%。它超過了我們之前提到的股價回報率。這在很大程度上是其股息支付的結果!

A Different Perspective

不同的觀點

While the broader market lost about 19% in the twelve months, Doctorglasses ChainLtd shareholders did even worse, losing 28% (even including dividends). However, it could simply be that the share price has been impacted by broader market jitters. It might be worth keeping an eye on the fundamentals, in case there's a good opportunity. On the bright side, long term shareholders have made money, with a gain of 9% per year over half a decade. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. For instance, we've identified 2 warning signs for Doctorglasses ChainLtd that you should be aware of.

儘管整個市場在過去的12個月中下跌了約19%,但是Doctorglasses Chain Ltd的股東甚至做得更差,損失了28%(包括分紅),但僅僅是股價受到了整個市場的影響。但值得關注的是,長揸該股的股東已經賺錢了,過去五年股東的年化收益率爲9%。因此,最近的拋售可能是一個機會,因此檢查基本數據以尋找長期增長趨勢的跡象值得一試。我發現長期觀察股價是評估業務表現的好方法,但要真正獲得洞見,我們需要考慮其他信息。例如,我們已經發現Doctorglasses Chain Ltd存在2個警示信號,您應該了解這一點。

But note: Doctorglasses ChainLtd may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast).

但請注意:Doctorglasses Chain Ltd可能不是最好的股票購買選擇,因此請查看此免費的有趣公司列表,其中包括以往的收益增長(以及未來的增長預測)信息。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

請注意,本文引用的市場回報反映了目前在中國交易所上市的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論